| Literature DB >> 27872706 |
Faezeh Moghadam Ariaee1, Maryam Hashemi2, Sara Amel Farzad1, Khalil Abnous1, Mohammad Ramezani2.
Abstract
OBJECTIVES: In recent years,Entities:
Keywords: Alkylcarboxylate chains Gene delivery; Non-viral vectors; Polypropyleneimine
Year: 2016 PMID: 27872706 PMCID: PMC5110658
Source DB: PubMed Journal: Iran J Basic Med Sci ISSN: 2008-3866 Impact factor: 2.699
Scheme 1Synthesis scheme for the preparation of PPI-PPI conjugates using 10-bromodecanoic acid as the linker.
Figure 1Modification of PPIs was demonstrated by comparing Fourier transform infrared (FTIR) spectra of unmodified PPIs, alkylcarboxylate PPIs and corresponding PPI-alkyl-PPI conjugates. Spectra A: upper spectrum: unmodified PPI G2, middle spectrum: alkylcarboxylate PPI G2, lower spectrum: PPI G2-alkyl-PPI G2 conjugate. Spectra B: upper spectrum: unmodified PPI G3, middle spectrum: alkylcarboxylate PPI G3, lower spectrum: PPI G3-alkyl-PPI G3 conjugate
Figure 2Characterization of the final PPI derivatives by 1HNMR. A: upper spectrum: PPI G2-alkyl-PPI G2 conjugate, lower spectrum: unmodified PPI G2. B: upper spectrum: PPI G3-alkyl- PPI G3 conjugate, lower spectrum: unmodified PPI G3
Figure 3The EtBr exclusion assay for pDNA complexed with PPI G2 or G3 derivatives
The particle size and zeta potential of PPI-alkyl-PPI conjugates at different C/P ratios
| Polymer | Carrier to plasmid ratio (C/P, wt/wt) | Particle size (nm) ± SD | Potential zeta (mV) ± SD |
|---|---|---|---|
| PPI G2 | 2 | 244.5 ± 14.4 | 9.75 ±0.5 |
| PPI G2 | 4 | 238.7 ± 9.3 | 10.11 ± 0.8 |
| PPI G2 | 6 | 231.2 ± 11.6 | 10.26 ± 2 |
| PPI G2-alkyl-PPI G2 | 2 | 153.7 ± 6.3 | 5.46 ± 1.5 |
| PPI G2-alkyl-PPI G2 | 4 | 147.9 ± 10.2 | 6.32 ± 0.2 |
| PPI G2-alkyl-PPI G2 | 6 | 142.4 ± 13.5 | 8.85 ± 0.6 |
| PPI G3 | 2 | 263.3 ± 19.6 | 8.02 ± 0.9 |
| PPI G3 | 4 | 255.2 ± 12 | 9.91 ± 2.3 |
| PPI G3 | 6 | 238.7 ± 9.6 | 9.45 ± 1.4 |
| PPI G3-alkyl-PPI G3 | 2 | 150.8 ± 10.8 | 8.08 ± 1.5 |
| PPI G3-alkyl-PPI G3 | 4 | 149.5 ± 4.9 | 8.23 ± 1.9 |
| PPI G3-alkyl-PPI G3 | 6 | 143.1 ± 5.7 | 12.51 ± 0.7 |
Figure 4Buffering capacity assay for PEI 25, PPI G2 and its derivative by titration of aqueous polymer solutions (0.4 mg/ml) with 0.1 M HCl
Figure 5The transfection efficiency of unmodified and modified PPIs after complexation with pDNA encoding the luciferase gene. PEI 25 kDa was used as control. * for P<0.05, ** for P<0.01, or *** for P<0.001 (t-test)
Figure 6The transfection efficiency of green fluorescent protein in Neuro 2A cells expressed at C/P ratio 2, 4, and 6 for PPIs and PPI derivatives by fluorescent microscopy. a) PEI 25 kDa as the control, b) PPI G2, c) PPI G2-alkyl-PPI G2 conjugate, d) PPI G3, e) PPI G3-alkyl-PPI G3 conjugate
Figure 7Expression of green fluorescent protein in Neuro-2a cells transfected with polyplexes prepared from an EGFP expressing plasmid DNA and PPIs or the PPIs modified with alkylcarboxylate chains. * for P<0.05, ** for P<0.01, or *** for P<0.001 (t-test)
Figure 8Flow cytometry histogram of cells transfected with polyplexes prepared from an EGFP expressing plasmid DNA and PPIs or the modified PPIs with alkylcarboxylate chains
Figure 9Cellular toxicity of PPI-alkyl-PPI conjugates at different C/P ratios. * for P <0.05, ** for P <0.01 or *** for P <0.001 (t-test)
Figure 10Transfection efficiency of PPI G2-alkyl-PPI G2 and unmodified PPI G2 in bafilomycin-treated cells